chr5-128084133-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001046.3(SLC12A2):c.179G>T(p.Gly60Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001046.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A2 | NM_001046.3 | c.179G>T | p.Gly60Val | missense_variant | 1/27 | ENST00000262461.7 | NP_001037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A2 | ENST00000262461.7 | c.179G>T | p.Gly60Val | missense_variant | 1/27 | 1 | NM_001046.3 | ENSP00000262461 | P4 | |
SLC12A2 | ENST00000343225.4 | c.179G>T | p.Gly60Val | missense_variant | 1/26 | 1 | ENSP00000340878 | A2 | ||
SLC12A2 | ENST00000509205.5 | c.179G>T | p.Gly60Val | missense_variant, NMD_transcript_variant | 1/27 | 1 | ENSP00000427109 | |||
SLC12A2 | ENST00000628403.2 | c.179G>T | p.Gly60Val | missense_variant | 1/26 | 5 | ENSP00000486323 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1145172Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 555852
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.179G>T (p.G60V) alteration is located in exon 1 (coding exon 1) of the SLC12A2 gene. This alteration results from a G to T substitution at nucleotide position 179, causing the glycine (G) at amino acid position 60 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.